SGLT2 Adjunct in T1D
NCT07591077 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 86
Last updated 2026-05-18
Summary
Effect of Sodium-Glucose Cotransporter (SGLT) 2 Inhibitors on Diabetic Nephropathy Progression in Adolescents with Type 1 Diabetes Mellitus
Conditions
- Type 1 Diabetes
- Nephropathy, Diabetic
Interventions
- DRUG
-
Empagliflozin (EMPA)
empagliflozin oral once daily
- OTHER
-
Placebo
placebo
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-20
- Primary Completion
- 2025-11-20
- Completion
- 2026-02-20
Countries
- Egypt
Study Locations
More Related Trials
-
Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors
NCT07421518 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
NCT05541484 ·Status: COMPLETED ·Phase: PHASE4
-
Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
NCT03091673 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Chlorthalidone in Type 1 Diabetes
NCT03325114 ·Status: TERMINATED ·Phase: PHASE2
-
SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus
NCT04201496 ·Status: COMPLETED ·Phase: PHASE1
-
Amitriptyline in Treating Hypoglycemia
NCT03591458 ·Status: TERMINATED ·Phase: PHASE2
-
Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM)
NCT00970567 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
NCT07038473 ·Status: RECRUITING ·Phase: NA
-
Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis
NCT05795309 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
NCT05762107 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus
NCT03111433 ·Status: COMPLETED ·Phase: PHASE2
-
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
NCT06981234 ·Status: RECRUITING ·Phase: PHASE2
-
Neuropeptide Therapy of Recent Onset Type 1 Diabetes
NCT02820558 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes
NCT06137586 ·Status: COMPLETED ·Phase: NA
-
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
NCT02660242 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
NCT07051564 ·Status: RECRUITING ·Phase: NA
-
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Anhydroglucitol in Children With Type 1 Diabetes
NCT05594706 ·Status: RECRUITING
-
The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia
NCT03286816 ·Status: COMPLETED ·Phase: NA
-
EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.
NCT07241702 ·Status: ACTIVE_NOT_RECRUITING
-
G-Pen™ for Hypoglycemia Rescue in T1D Patients
NCT02423980 ·Status: COMPLETED ·Phase: PHASE2
-
Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
NCT00133809 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Sitagliptin in Relatives of T1D Patients
NCT05219409 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
NCT00505375 ·Status: COMPLETED ·Phase: PHASE2
-
Recurrent Hypoglycemia in Type 1 Diabetes (Aim 1)
NCT03410277 ·Status: COMPLETED ·Phase: NA